Biotek-snakken — August 2020
-
"
The milestone was achieved with the delivery of GMP clinical trial supply to Merck KGaA, Darmstadt, Germany for the Phase 1 clinical trial testing of M1231 pursuant to a 2014 license agreement. As part of the agreement, Sutro will manufacture M1231 for early clinical supply and is eligible for further milestones and royalties. " -
-
De har en aftale med EMD Serono omkring det bispecifikke ADC. Serono ejes af tyske Merck. Så har de en aftale med amerikanske Mervk omkring Cytokine derivatives. To forskellige selskaber - altså de to Merck er forskellige selskaber. Ved ikke om det er det du tænker på.
-
@sukkeralf - ikke udmiddelbart nyheder i ZYME, men synes faktisk den var kommet relativt langt ned....har selv taget en ekstra portion under kurs 30. Forventer altså vi har set noget bund for denne gang. Mener først der kommer nyt i november (med mindre noget kommer dumpende).
-
HANSA BIOPHARMA - EU-godkendelse af IdefirixTM (imlifidase) https://www.proinvestor.com/boards/86280
-
Hansa Biopharma: er det sell on facts eller er der nogle betingelser i den godkendelse som ikke var ventet. Jeg forstod det sådan at alt var som forventet i forberedelse med den foreløbige godkendelse af Imlifidase. Er der noget jeg har misforstået eller er der bare snak
om kortsigtet støj...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind